Aptivus and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Aptivus (tipranavir), especially for people who are male, 50-59 old, have been taking the drug for 1 - 2 years also take Norvir, and have Hiv infection.

The phase IV clinical study analyzes which people have Stroke when taking Aptivus. It is created by eHealthMe based on reports of 1,057 people who have side effects when taking Aptivus from the FDA, and is updated regularly.

What is Aptivus?

Aptivus has active ingredients of tipranavir. eHealthMe is studying from 1,060 Aptivus users. Check the latest studies of Aptivus.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,335 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On Apr, 05, 2026

1,057 people reported to have side effects when taking Aptivus.
Among them, 12 people (1.14%) have Stroke.

Among these 12 people:

How long have people been on Aptivus when they have Stroke? *

What is the gender of people who have Stroke when taking Aptivus? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Stroke when taking Aptivus? *

What are other drugs people take besides Aptivus? *

Trizivir: 4 people, 33.33%
Norvir: 4 people, 33.33%
Lansoprazole: 3 people, 25.00%
Azithromycin: 3 people, 25.00%
Fuzeon: 3 people, 25.00%
Lamivudine: 3 people, 25.00%
Amlodipine Besylate: 2 people, 16.67%
Norvasc: 2 people, 16.67%
Metformin Hydrochloride: 2 people, 16.67%
Captopril: 2 people, 16.67%

What are other side effects people have besides Stroke? *

Reversible Ischaemic Neurological Deficit (transient stroke resulting from a decrease in cerebral blood flow): 4 people, 33.33%
High Blood Pressure: 4 people, 33.33%
High Blood Cholesterol: 4 people, 33.33%
Carotid Artery Stenosis (narrowing of carotid artery): 4 people, 33.33%
Haemorrhage Intracranial (bleeding within the skull): 3 people, 25.00%
Speech Impairment (Adult) (inability to speak (adult)): 2 people, 16.67%
Paresis (a condition of muscular weakness): 2 people, 16.67%
Monoparesis (one limb is very weak, but not completely paralyzed): 2 people, 16.67%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 8.33%
Movement - Uncoordinated: 1 person, 8.33%

What are the existing conditions these people have? *

Hiv Infection: 10 people, 83.33%
Diabetes: 5 people, 41.67%
High Blood Pressure: 4 people, 33.33%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 16.67%
Parkinson's Disease: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Aptivus and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aptivus:

Aptivus (1,060 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Aptivus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,335 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,028 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tipranavir (the active ingredients of Aptivus) and Aptivus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.